 James Liu
Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogens | 9 | 2020 | 367 | 2.520 |
Why?
| | Postmenopause | 8 | 2021 | 371 | 1.650 |
Why?
| | Leiomyoma | 3 | 2021 | 56 | 1.360 |
Why?
| | Norpregnadienes | 2 | 2021 | 6 | 1.310 |
Why?
| | Estrogen Replacement Therapy | 8 | 2020 | 142 | 1.260 |
Why?
| | Estradiol | 6 | 2021 | 528 | 1.260 |
Why?
| | Pituitary Neoplasms | 4 | 2024 | 197 | 1.140 |
Why?
| | Vaginal Creams, Foams, and Jellies | 2 | 2018 | 4 | 1.120 |
Why?
| | Dyspareunia | 2 | 2018 | 8 | 1.120 |
Why?
| | Vulva | 2 | 2018 | 24 | 1.110 |
Why?
| | Adenoma | 3 | 2024 | 220 | 1.050 |
Why?
| | Skull Base Neoplasms | 4 | 2024 | 31 | 1.030 |
Why?
| | Vagina | 4 | 2021 | 194 | 1.010 |
Why?
| | Cranial Sinuses | 1 | 2024 | 14 | 0.870 |
Why?
| | Neuroma, Acoustic | 2 | 2022 | 50 | 0.840 |
Why?
| | Ovary | 4 | 2020 | 225 | 0.810 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2023 | 51 | 0.770 |
Why?
| | Contraceptive Devices, Female | 1 | 2021 | 11 | 0.700 |
Why?
| | Ovarian Neoplasms | 3 | 2020 | 580 | 0.700 |
Why?
| | Pregnenediones | 1 | 2021 | 15 | 0.690 |
Why?
| | Hydrocarbons, Fluorinated | 1 | 2020 | 6 | 0.660 |
Why?
| | Uterine Neoplasms | 2 | 2018 | 92 | 0.660 |
Why?
| | Microvascular Decompression Surgery | 1 | 2020 | 6 | 0.660 |
Why?
| | Trigeminal Nerve | 1 | 2020 | 27 | 0.660 |
Why?
| | Hormone Antagonists | 1 | 2020 | 34 | 0.660 |
Why?
| | Trigeminal Neuralgia | 1 | 2020 | 21 | 0.650 |
Why?
| | Menopause, Premature | 1 | 2020 | 12 | 0.640 |
Why?
| | Salpingo-oophorectomy | 1 | 2020 | 19 | 0.640 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2018 | 170 | 0.620 |
Why?
| | Bacteriophages | 1 | 2021 | 107 | 0.610 |
Why?
| | Frailty | 1 | 2022 | 173 | 0.600 |
Why?
| | Brain Neoplasms | 3 | 2025 | 1304 | 0.590 |
Why?
| | Neurosurgical Procedures | 5 | 2024 | 208 | 0.580 |
Why?
| | Uterine Hemorrhage | 1 | 2018 | 38 | 0.580 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2020 | 213 | 0.580 |
Why?
| | Androgen Antagonists | 1 | 2019 | 93 | 0.570 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2250 | 0.550 |
Why?
| | Vaginal Diseases | 1 | 2017 | 20 | 0.550 |
Why?
| | Thyrotropin | 1 | 2018 | 117 | 0.550 |
Why?
| | Hypothyroidism | 1 | 2018 | 73 | 0.540 |
Why?
| | Hysterectomy | 2 | 2018 | 138 | 0.540 |
Why?
| | Osteoporosis | 1 | 2020 | 244 | 0.540 |
Why?
| | Glioblastoma | 1 | 2021 | 347 | 0.530 |
Why?
| | Cardiovascular System | 1 | 2018 | 137 | 0.510 |
Why?
| | Pyrimidines | 1 | 2020 | 477 | 0.510 |
Why?
| | Testosterone | 2 | 2019 | 404 | 0.490 |
Why?
| | Endoscopy | 3 | 2019 | 322 | 0.480 |
Why?
| | Transgender Persons | 1 | 2019 | 198 | 0.470 |
Why?
| | Humans | 52 | 2025 | 141187 | 0.460 |
Why?
| | Skull Base | 3 | 2022 | 54 | 0.460 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2018 | 179 | 0.460 |
Why?
| | Female | 36 | 2025 | 75515 | 0.440 |
Why?
| | Double-Blind Method | 6 | 2021 | 1983 | 0.410 |
Why?
| | Lipids | 1 | 2018 | 689 | 0.400 |
Why?
| | Pneumocephalus | 1 | 2013 | 5 | 0.400 |
Why?
| | Treatment Outcome | 9 | 2024 | 11120 | 0.380 |
Why?
| | Postoperative Complications | 4 | 2024 | 2797 | 0.380 |
Why?
| | Reproductive Medicine | 1 | 2012 | 15 | 0.370 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2012 | 51 | 0.360 |
Why?
| | Menopause | 4 | 2020 | 320 | 0.350 |
Why?
| | Endocrinology | 1 | 2012 | 76 | 0.350 |
Why?
| | Hot Flashes | 1 | 2012 | 87 | 0.340 |
Why?
| | Atrophy | 4 | 2021 | 193 | 0.330 |
Why?
| | Sleep Deprivation | 1 | 2012 | 200 | 0.310 |
Why?
| | Intraoperative Complications | 2 | 2023 | 148 | 0.310 |
Why?
| | Meningioma | 2 | 2021 | 95 | 0.280 |
Why?
| | Meningeal Neoplasms | 2 | 2021 | 103 | 0.280 |
Why?
| | Blood Glucose | 1 | 2018 | 2269 | 0.270 |
Why?
| | Middle Aged | 15 | 2025 | 34434 | 0.270 |
Why?
| | Gonadotropins, Pituitary | 1 | 2007 | 22 | 0.260 |
Why?
| | Ovarian Hyperstimulation Syndrome | 1 | 2007 | 7 | 0.260 |
Why?
| | Insulin | 1 | 2018 | 2482 | 0.260 |
Why?
| | Adult | 17 | 2025 | 39177 | 0.250 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2018 | 556 | 0.250 |
Why?
| | Cultural Evolution | 1 | 2025 | 4 | 0.240 |
Why?
| | Social Learning | 1 | 2025 | 5 | 0.240 |
Why?
| | Moyamoya Disease | 1 | 2025 | 21 | 0.230 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2025 | 31 | 0.230 |
Why?
| | Follicle Stimulating Hormone | 1 | 2007 | 243 | 0.230 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 33 | 0.230 |
Why?
| | Administration, Intravaginal | 4 | 2021 | 17 | 0.230 |
Why?
| | Gynatresia | 2 | 2020 | 2 | 0.230 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2025 | 79 | 0.220 |
Why?
| | Neuroendoscopy | 1 | 2024 | 26 | 0.220 |
Why?
| | Jugular Veins | 1 | 2024 | 42 | 0.210 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 150 | 0.210 |
Why?
| | Microsurgery | 1 | 2024 | 77 | 0.210 |
Why?
| | Drainage | 2 | 2015 | 174 | 0.200 |
Why?
| | Craniotomy | 1 | 2023 | 81 | 0.190 |
Why?
| | Denervation | 1 | 2022 | 24 | 0.190 |
Why?
| | Pheochromocytoma | 1 | 2023 | 57 | 0.190 |
Why?
| | Insulin Resistance | 2 | 2023 | 1225 | 0.190 |
Why?
| | Paraganglioma | 1 | 2023 | 53 | 0.190 |
Why?
| | Health Status Disparities | 1 | 2025 | 297 | 0.190 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2023 | 89 | 0.180 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3469 | 0.180 |
Why?
| | Progesterone | 2 | 2021 | 260 | 0.180 |
Why?
| | Wakefulness | 1 | 2023 | 172 | 0.180 |
Why?
| | Cerebral Veins | 1 | 2021 | 16 | 0.180 |
Why?
| | Risk Factors | 5 | 2022 | 10438 | 0.180 |
Why?
| | Ethinyl Estradiol | 1 | 2021 | 15 | 0.180 |
Why?
| | Endometrium | 2 | 2015 | 61 | 0.170 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 692 | 0.170 |
Why?
| | Phytoestrogens | 1 | 2020 | 17 | 0.170 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2020 | 32 | 0.170 |
Why?
| | Contraceptive Agents | 1 | 2021 | 66 | 0.160 |
Why?
| | Hysteroscopy | 1 | 2020 | 13 | 0.160 |
Why?
| | Pregnancy | 6 | 2021 | 7070 | 0.160 |
Why?
| | Genes, BRCA2 | 1 | 2020 | 30 | 0.160 |
Why?
| | Genes, BRCA1 | 1 | 2020 | 41 | 0.160 |
Why?
| | Aged | 8 | 2025 | 24574 | 0.160 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 264 | 0.160 |
Why?
| | Drug Combinations | 1 | 2021 | 358 | 0.160 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 40 | 0.160 |
Why?
| | Histones | 1 | 2025 | 639 | 0.160 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2021 | 168 | 0.160 |
Why?
| | Neuroprotection | 1 | 2019 | 43 | 0.150 |
Why?
| | Body Mass Index | 2 | 2018 | 2382 | 0.150 |
Why?
| | Seizures | 1 | 2023 | 442 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 220 | 0.150 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 39 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1282 | 0.150 |
Why?
| | Hormone Replacement Therapy | 2 | 2020 | 101 | 0.150 |
Why?
| | Complementary Therapies | 1 | 2020 | 89 | 0.150 |
Why?
| | History, 20th Century | 1 | 2020 | 329 | 0.150 |
Why?
| | Amenorrhea | 1 | 2018 | 31 | 0.150 |
Why?
| | Umbilicus | 1 | 2018 | 19 | 0.140 |
Why?
| | Retrospective Studies | 5 | 2025 | 16273 | 0.140 |
Why?
| | Pruritus Vulvae | 1 | 2018 | 1 | 0.140 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2018 | 4 | 0.140 |
Why?
| | Ohio | 1 | 2018 | 140 | 0.140 |
Why?
| | Cerebrospinal Fluid Leak | 2 | 2017 | 63 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 464 | 0.140 |
Why?
| | Receptors, Progesterone | 2 | 2021 | 337 | 0.140 |
Why?
| | Administration, Oral | 1 | 2020 | 803 | 0.140 |
Why?
| | Administration, Topical | 1 | 2018 | 150 | 0.140 |
Why?
| | Symptom Assessment | 1 | 2018 | 129 | 0.130 |
Why?
| | Sinus Pericranii | 1 | 2016 | 1 | 0.130 |
Why?
| | Superior Sagittal Sinus | 1 | 2016 | 4 | 0.130 |
Why?
| | Transverse Sinuses | 1 | 2016 | 8 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 400 | 0.130 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 367 | 0.130 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 169 | 0.130 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 1123 | 0.120 |
Why?
| | Machine Learning | 1 | 2022 | 553 | 0.120 |
Why?
| | Cross-Over Studies | 1 | 2018 | 578 | 0.120 |
Why?
| | Laparoscopy | 2 | 2018 | 463 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2021 | 712 | 0.120 |
Why?
| | Decorin | 1 | 2015 | 7 | 0.120 |
Why?
| | Robotic Surgical Procedures | 1 | 2018 | 149 | 0.120 |
Why?
| | Surgical Flaps | 2 | 2017 | 144 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2017 | 179 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2021 | 2504 | 0.120 |
Why?
| | Algorithms | 2 | 2015 | 1763 | 0.120 |
Why?
| | Peritoneum | 1 | 2015 | 43 | 0.120 |
Why?
| | Male | 8 | 2025 | 69783 | 0.120 |
Why?
| | Myometrium | 1 | 2015 | 39 | 0.110 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2015 | 19 | 0.110 |
Why?
| | Proteoglycans | 1 | 2015 | 109 | 0.110 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 35 | 0.110 |
Why?
| | Diagnosis, Differential | 2 | 2011 | 1498 | 0.110 |
Why?
| | Product Labeling | 1 | 2014 | 10 | 0.110 |
Why?
| | Endometriosis | 1 | 2015 | 53 | 0.110 |
Why?
| | Biomarkers | 2 | 2018 | 4174 | 0.110 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5200 | 0.100 |
Why?
| | Age Factors | 2 | 2018 | 3292 | 0.100 |
Why?
| | Young Adult | 4 | 2025 | 13673 | 0.100 |
Why?
| | Optic Chiasm | 1 | 2013 | 18 | 0.100 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 55 | 0.100 |
Why?
| | Infertility, Female | 2 | 2020 | 108 | 0.100 |
Why?
| | Risk Assessment | 1 | 2022 | 3490 | 0.090 |
Why?
| | Fertility Agents, Female | 1 | 2012 | 21 | 0.090 |
Why?
| | Triptorelin Pamoate | 1 | 2012 | 19 | 0.090 |
Why?
| | Mobile Applications | 1 | 2015 | 185 | 0.090 |
Why?
| | Chorionic Gonadotropin | 1 | 2012 | 78 | 0.090 |
Why?
| | Pregnancy, Ectopic | 1 | 2012 | 54 | 0.090 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2012 | 40 | 0.090 |
Why?
| | Melanoma | 1 | 2019 | 772 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2560 | 0.090 |
Why?
| | Vasomotor System | 1 | 2012 | 47 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1222 | 0.090 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5636 | 0.090 |
Why?
| | Spermatocidal Agents | 1 | 2010 | 7 | 0.090 |
Why?
| | Nonoxynol | 1 | 2010 | 4 | 0.090 |
Why?
| | Weight Reduction Programs | 1 | 2012 | 117 | 0.080 |
Why?
| | Betaine | 1 | 2010 | 64 | 0.080 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2010 | 98 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2892 | 0.080 |
Why?
| | Nose | 2 | 2022 | 65 | 0.070 |
Why?
| | Reference Values | 2 | 2020 | 805 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5929 | 0.070 |
Why?
| | Ovulation | 1 | 2008 | 40 | 0.070 |
Why?
| | Luteal Phase | 1 | 2008 | 46 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 642 | 0.070 |
Why?
| | Cohort Studies | 1 | 2018 | 5799 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2746 | 0.060 |
Why?
| | Quality of Life | 1 | 2018 | 2999 | 0.060 |
Why?
| | Fertility | 1 | 2007 | 165 | 0.060 |
Why?
| | Obesity | 2 | 2023 | 3004 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 3 | 2017 | 3709 | 0.050 |
Why?
| | Embryo Transfer | 1 | 2004 | 35 | 0.050 |
Why?
| | Ovulation Induction | 1 | 2004 | 58 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2006 | 330 | 0.050 |
Why?
| | Mental Disorders | 1 | 2013 | 1120 | 0.050 |
Why?
| | Infertility | 1 | 2004 | 55 | 0.050 |
Why?
| | Piperazines | 1 | 2006 | 354 | 0.050 |
Why?
| | Carcinoembryonic Antigen | 1 | 2023 | 38 | 0.050 |
Why?
| | Succinate Dehydrogenase | 1 | 2023 | 52 | 0.050 |
Why?
| | Mice | 3 | 2025 | 18048 | 0.050 |
Why?
| | United States | 4 | 2025 | 15220 | 0.050 |
Why?
| | Ultrasonography | 1 | 2007 | 755 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 898 | 0.050 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 167 | 0.050 |
Why?
| | Otolaryngologists | 1 | 2022 | 14 | 0.050 |
Why?
| | ErbB Receptors | 1 | 2025 | 610 | 0.050 |
Why?
| | Parietal Lobe | 1 | 2021 | 60 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 282 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2004 | 287 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2166 | 0.040 |
Why?
| | Illinois | 1 | 2020 | 44 | 0.040 |
Why?
| | Chicago | 1 | 2020 | 61 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2020 | 32 | 0.040 |
Why?
| | Hormones | 1 | 2020 | 140 | 0.040 |
Why?
| | Fertility Preservation | 1 | 2020 | 54 | 0.040 |
Why?
| | NF-kappa B | 1 | 2023 | 692 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1431 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 354 | 0.040 |
Why?
| | Incidence | 1 | 2025 | 2794 | 0.040 |
Why?
| | Choice Behavior | 1 | 2020 | 172 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 17 | 0.040 |
Why?
| | Abdominal Wall | 1 | 2018 | 26 | 0.040 |
Why?
| | Animals | 3 | 2025 | 37657 | 0.030 |
Why?
| | Parity | 1 | 2018 | 110 | 0.030 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2018 | 67 | 0.030 |
Why?
| | Tumor Burden | 1 | 2018 | 312 | 0.030 |
Why?
| | Aging | 1 | 2008 | 1892 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2023 | 816 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2021 | 334 | 0.030 |
Why?
| | Angiography, Digital Subtraction | 1 | 2016 | 46 | 0.030 |
Why?
| | Recurrence | 1 | 2020 | 1110 | 0.030 |
Why?
| | Drug Therapy | 1 | 2017 | 86 | 0.030 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2017 | 109 | 0.030 |
Why?
| | Insurance, Health | 1 | 2018 | 299 | 0.030 |
Why?
| | Promegestone | 1 | 2015 | 33 | 0.030 |
Why?
| | Radiotherapy | 1 | 2017 | 208 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 419 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 145 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2023 | 1597 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 212 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 633 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1819 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7856 | 0.030 |
Why?
| | Income | 1 | 2015 | 201 | 0.030 |
Why?
| | Immunotherapy | 1 | 2019 | 640 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1306 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 398 | 0.030 |
Why?
| | Educational Status | 1 | 2015 | 463 | 0.030 |
Why?
| | Endometrial Neoplasms | 1 | 2015 | 197 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1444 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1234 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2023 | 5887 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1081 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1737 | 0.020 |
Why?
| | Gels | 1 | 2010 | 83 | 0.020 |
Why?
| | Societies, Medical | 1 | 2015 | 855 | 0.020 |
Why?
| | Adolescent | 2 | 2025 | 22007 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11457 | 0.020 |
Why?
| | Pregnanediol | 1 | 2008 | 16 | 0.020 |
Why?
| | Estrone | 1 | 2008 | 36 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 3588 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 961 | 0.020 |
Why?
| | Sildenafil Citrate | 1 | 2006 | 59 | 0.020 |
Why?
| | Sulfones | 1 | 2006 | 110 | 0.010 |
Why?
| | Purines | 1 | 2006 | 179 | 0.010 |
Why?
| | Women's Health | 1 | 2006 | 311 | 0.010 |
Why?
| | Prospective Studies | 1 | 2015 | 7739 | 0.010 |
Why?
|
|
Liu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|